AstraZeneca Nexium I.V. Available In May As Second-Line Reflux Therapy
This article was originally published in The Pink Sheet Daily
Executive Summary
Like Nexium I.V., TAP’s Prevacid intravenous dosage form is approved for use in GERD patients who cannot take oral therapy. Wyeth’s Protonix is the only intravenous proton pump inhibitor approved for first-line use.